Craig Hallum Initiates Coverage on Kindred Healthcare (KND)
Equities research analysts at Craig Hallum began coverage on shares of Kindred Healthcare (NYSE:KND) in a research note issued to investors on Friday. The firm set a “buy” rating and a $25.00 price target on the stock. Craig Hallum’s price target would suggest a potential upside of 2.92% from the stock’s previous close.
Kindred Healthcare (NYSE:KND) opened at 24.29 on Friday. Kindred Healthcare has a 52 week low of $12.50 and a 52 week high of $26.72. The stock has a 50-day moving average of $24.22 and a 200-day moving average of $20.60. The company’s market cap is $1.331 billion.
Kindred Healthcare (NYSE:KND) last released its earnings data on Wednesday, May 7th. The company reported $0.32 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.32. The company had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter last year, the company posted $0.49 earnings per share. Kindred Healthcare’s revenue was up 1.9% compared to the same quarter last year. On average, analysts predict that Kindred Healthcare will post $1.16 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, June 11th. Investors of record on Wednesday, May 21st will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.98%. The ex-dividend date of this dividend is Monday, May 19th.
Several other analysts have also recently commented on the stock. Analysts at Susquehanna raised their price target on shares of Kindred Healthcare from $25.00 to $27.00 in a research note on Friday, May 9th. Separately, analysts at RBC Capital upgraded shares of Kindred Healthcare from a “sector perform” rating to an “outperform” rating in a research note on Monday, April 7th. They now have a $42.00 price target on the stock, up previously from $18.00. Finally, analysts at Barclays raised their price target on shares of Kindred Healthcare from $26.00 to $30.00 in a research note on Tuesday, April 1st. They now have an “overweight” rating on the stock. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $28.38.
Kindred Healthcare, Inc is a healthcare services company that through its subsidiaries operates transitional care (NYSE:KND) hospitals, inpatient rehabilitation hospitals (IRFs), nursing and rehabilitation centers, assisted living facilities, a contract rehabilitation services business and a home health and hospice business across the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.